Literature DB >> 24644069

In search of a candidate pathogen for giant cell arteritis: sequencing-based characterization of the giant cell arteritis microbiome.

Ami S Bhatt1, Veronica E Manzo, Chandra Sekhar Pedamallu, Fujiko Duke, Diana Cai, Don C Bienfang, Robert F Padera, Matthew Meyerson, William P Docken.   

Abstract

OBJECTIVE: To characterize the microbiome of the temporal artery in patients with giant cell arteritis (GCA), and to apply an unbiased and comprehensive shotgun sequencing-based approach to determine whether there is an enrichment of candidate pathogens in the affected tissue.
METHODS: Temporal artery biopsy specimens were collected from patients at a single institution over a period of 4 years, and unbiased DNA sequencing was performed on 17 formalin-fixed, paraffin-embedded specimens. Twelve of the 17 patients fulfilled the clinical and histopathologic criteria for GCA, and the other 5 patients served as controls. Using PathSeq software, human DNA sequences were computationally subtracted, and the remaining non-human DNA sequences were taxonomically classified using a comprehensive microbial sequence database. The relative abundance of microbes was inferred based on read counts assigned to each organism. Comparison of the microbial diversity between GCA cases and controls was carried out using hierarchical clustering and linear discriminant analysis of effect size.
RESULTS: Propionibacterium acnes and Escherichia coli were the most abundant microorganisms in 16 of the 17 samples, and Moraxella catarrhalis was the most abundant organism in 1 control sample. Pathogens previously described to be correlated with GCA were not differentially abundant in cases compared to controls. There was not a significant burden of likely pathogenic viruses.
CONCLUSION: DNA sequencing of temporal artery biopsy specimens from GCA cases, in comparison with non-GCA controls, showed no evidence of previously identified candidate GCA pathogens. A single pathogen was not clearly and consistently associated with GCA in this case series.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24644069      PMCID: PMC4113339          DOI: 10.1002/art.38631

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  14 in total

1.  Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study.

Authors:  Carlo Salvarani; Enrico Farnetti; Bruno Casali; Davide Nicoli; Liu Wenlan; GianLuigi Bajocchi; PierLuigi Macchioni; Giovanni Lo Scocco; Maria Grazia Catanoso; Luigi Boiardi; Fabrizio Cantini
Journal:  Arthritis Rheum       Date:  2002-11

2.  Identification of candidate microbial sequences from inflammatory lesion of giant cell arteritis.

Authors:  Lynn K Gordon; Melissa Goldman; Hallie Sandusky; Nurit Ziv; Gary S Hoffman; Todd Goodglick; Lee Goodglick
Journal:  Clin Immunol       Date:  2004-06       Impact factor: 3.969

3.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

Authors:  Aleksandar D Kostic; Dirk Gevers; Chandra Sekhar Pedamallu; Monia Michaud; Fujiko Duke; Ashlee M Earl; Akinyemi I Ojesina; Joonil Jung; Adam J Bass; Josep Tabernero; José Baselga; Chen Liu; Ramesh A Shivdasani; Shuji Ogino; Bruce W Birren; Curtis Huttenhower; Wendy S Garrett; Matthew Meyerson
Journal:  Genome Res       Date:  2011-10-18       Impact factor: 9.043

4.  Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.

Authors:  Ami S Bhatt; Samuel S Freeman; Alex F Herrera; Chandra Sekhar Pedamallu; Dirk Gevers; Fujiko Duke; Joonil Jung; Monia Michaud; Bruce J Walker; Sarah Young; Ashlee M Earl; Aleksander D Kostic; Akinyemi I Ojesina; Robert Hasserjian; Karen K Ballen; Yi-Bin Chen; Gabriela Hobbs; Joseph H Antin; Robert J Soiffer; Lindsey R Baden; Wendy S Garrett; Jason L Hornick; Francisco M Marty; Matthew Meyerson
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

5.  The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation.

Authors:  S E Gabriel; M Espy; D D Erdman; J Bjornsson; T F Smith; G G Hunder
Journal:  Arthritis Rheum       Date:  1999-06

6.  Detection of varicella zoster virus DNA in some patients with giant cell arteritis.

Authors:  B M Mitchell; R L Font
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-10       Impact factor: 4.799

7.  The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern.

Authors:  C Salvarani; S E Gabriel; W M O'Fallon; G G Hunder
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Topographical and temporal diversity of the human skin microbiome.

Authors:  Elizabeth A Grice; Heidi H Kong; Sean Conlan; Clayton B Deming; Joie Davis; Alice C Young; Gerard G Bouffard; Robert W Blakesley; Patrick R Murray; Eric D Green; Maria L Turner; Julia A Segre
Journal:  Science       Date:  2009-05-29       Impact factor: 47.728

10.  Metagenomic biomarker discovery and explanation.

Authors:  Nicola Segata; Jacques Izard; Levi Waldron; Dirk Gevers; Larisa Miropolsky; Wendy S Garrett; Curtis Huttenhower
Journal:  Genome Biol       Date:  2011-06-24       Impact factor: 13.583

View more
  13 in total

1.  Absence of Bacteria in the Temporal Arteries of Patients with Giant Cell Arteritis.

Authors:  Curry L Koening; Spencer G Peterson; Nicole L Podnecky; Herbert P Schweizer; Dean Y Li; Bradley J Katz
Journal:  J Clin Rheumatol       Date:  2016-01       Impact factor: 3.517

Review 2.  Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Authors:  Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

Review 3.  The microbiome in autoimmune rheumatic disease.

Authors:  Maximilian F Konig
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-02-07       Impact factor: 4.098

Review 4.  Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update.

Authors:  Gideon Nesher; Gabriel S Breuer
Journal:  Rambam Maimonides Med J       Date:  2016-10-31

Review 5.  The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review.

Authors:  Rossella Talotta; Fabiola Atzeni; Maria Chiara Ditto; Maria Chiara Gerardi; Piercarlo Sarzi-Puttini
Journal:  J Immunol Res       Date:  2017-08-01       Impact factor: 4.818

Review 6.  Clinical Evidence for the Microbiome in Inflammatory Diseases.

Authors:  Ann E Slingerland; Zaker Schwabkey; Diana H Wiesnoski; Robert R Jenq
Journal:  Front Immunol       Date:  2017-04-12       Impact factor: 7.561

7.  Microbiomes of Inflammatory Thoracic Aortic Aneurysms Due to Giant Cell Arteritis and Clinically Isolated Aortitis Differ From Those of Non-Inflammatory Aneurysms.

Authors:  Ted M Getz; Gary S Hoffman; Roshan Padmanabhan; Alexandra Villa-Forte; Eric E Roselli; Eugene Blackstone; Douglas Johnston; Gosta Pettersson; Edward Soltesz; Lars G Svensson; Leonard H Calabrese; Alison H Clifford; Charis Eng
Journal:  Pathog Immun       Date:  2019-03-15

Review 8.  Pathophysiological Relationship between Infections and Systemic Vasculitis.

Authors:  Carolina Muñoz-Grajales; Juan C Pineda
Journal:  Autoimmune Dis       Date:  2015-07-07

Review 9.  T cell-macrophage interactions and granuloma formation in vasculitis.

Authors:  Marc Hilhorst; Tsuyoshi Shirai; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2014-09-12       Impact factor: 7.561

10.  Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis.

Authors:  Christien Rondaan; Kornelis S M van der Geest; Elisabeth Eelsing; Annemieke M H Boots; Nicolaas A Bos; Johanna Westra; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2017-10-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.